Skip to main content

Hyperkalemia associated with intravenous labetalol therapy for acute hypertension in renal transplant recipients.

Publication ,  Journal Article
Arthur, S; Greenberg, A
Published in: Clin Nephrol
June 1990

Three renal transplant recipients developed potentially life-threatening hyperkalemia after receiving intravenous labetalol for postoperative hypertension. Even as beta-adrenergic agonists find increasing use in the therapy of acute hyperkalemia, physicians should be aware of the potential of beta blockers to cause profound elevations of serum potassium.

Duke Scholars

Published In

Clin Nephrol

ISSN

0301-0430

Publication Date

June 1990

Volume

33

Issue

6

Start / End Page

269 / 271

Location

Germany

Related Subject Headings

  • Urology & Nephrology
  • Postoperative Complications
  • Middle Aged
  • Male
  • Labetalol
  • Kidney Transplantation
  • Kidney Failure, Chronic
  • Infusions, Intravenous
  • Hypertension
  • Hyperkalemia
 

Citation

APA
Chicago
ICMJE
MLA
NLM

Published In

Clin Nephrol

ISSN

0301-0430

Publication Date

June 1990

Volume

33

Issue

6

Start / End Page

269 / 271

Location

Germany

Related Subject Headings

  • Urology & Nephrology
  • Postoperative Complications
  • Middle Aged
  • Male
  • Labetalol
  • Kidney Transplantation
  • Kidney Failure, Chronic
  • Infusions, Intravenous
  • Hypertension
  • Hyperkalemia